Showing 1 - 8 results of 8 for search 'Lena Heinbockel', query time: 0.03s Refine Results
  1. 1
    Biophysical analysis of the interaction of the serum protein human β2GPI with bacterial lipopolysaccharide

    Biophysical analysis of the interaction of the serum protein human β2GPI with bacterial lipopolysaccharide by Anna Gries, Ruth Prassl, Satoshi Fukuoka, Manfred Rössle, Yani Kaconis, Lena Heinbockel, Thomas Gutsmann, Klaus Brandenburg

    Published 2014-01-01
    Get full text
    Article
  2. 2
    The Synthetic Antimicrobial Peptide 19-2.5 Interacts with Heparanase and Heparan Sulfate in Murine and Human Sepsis.

    The Synthetic Antimicrobial Peptide 19-2.5 Interacts with Heparanase and Heparan Sulfate in Murine and Human Sepsis. by Lukas Martin, Rebecca De Santis, Patrick Koczera, Nadine Simons, Hajo Haase, Lena Heinbockel, Klaus Brandenburg, Gernot Marx, Tobias Schuerholz

    Published 2015-01-01
    Get full text
    Article
  3. 3
    Toxicological and Safety Pharmacological Profiling of the Anti-Infective and Anti-Inflammatory Peptide Pep19-2.5

    Toxicological and Safety Pharmacological Profiling of the Anti-Infective and Anti-Inflammatory Peptide Pep19-2.5 by Clemens Möller, Lena Heinbockel, Patrick Garidel, Thomas Gutsmann, Karl Mauss, Günther Weindl, Satoshi Fukuoka, Dominik Loser, Timm Danker, Klaus Brandenburg

    Published 2022-12-01
    Get full text
    Article
  4. 4
    Peptide 19-2.5 inhibits heparan sulfate-triggered inflammation in murine cardiomyocytes stimulated with human sepsis serum.

    Peptide 19-2.5 inhibits heparan sulfate-triggered inflammation in murine cardiomyocytes stimulated with human sepsis serum. by Lukas Martin, Susanne Schmitz, Rebecca De Santis, Sabine Doemming, Hajo Haase, Janine Hoeger, Lena Heinbockel, Klaus Brandenburg, Gernot Marx, Tobias Schuerholz

    Published 2015-01-01
    Get full text
    Article
  5. 5
    Inhibition of Lipopolysaccharide- and Lipoprotein-Induced Inflammation by Antitoxin Peptide Pep19-2.5

    Inhibition of Lipopolysaccharide- and Lipoprotein-Induced Inflammation by Antitoxin Peptide Pep19-2.5 by Lena Heinbockel, Günther Weindl, Guillermo Martinez-de-Tejada, Wilmar Correa, Susana Sanchez-Gomez, Sergio Bárcena-Varela, Torsten Goldmann, Patrick Garidel, Thomas Gutsmann, Klaus Brandenburg

    Published 2018-07-01
    Get full text
    Article
  6. 6
    Anti-Infective and Anti-Inflammatory Mode of Action of Peptide 19-2.5

    Anti-Infective and Anti-Inflammatory Mode of Action of Peptide 19-2.5 by Lena Heinbockel, Günther Weindl, Wilmar Correa, Julius Brandenburg, Norbert Reiling, Karl-Heinz Wiesmüller, Tobias Schürholz, Thomas Gutsmann, Guillermo Martinez de Tejada, Karl Mauss, Klaus Brandenburg

    Published 2021-02-01
    Get full text
    Article
  7. 7
    Therapeutical Administration of Peptide Pep19-2.5 and Ibuprofen Reduces Inflammation and Prevents Lethal Sepsis.

    Therapeutical Administration of Peptide Pep19-2.5 and Ibuprofen Reduces Inflammation and Prevents Lethal Sepsis. by Lena Heinbockel, Sebastian Marwitz, Sergio Barcena Varela, Raquel Ferrer-Espada, Norbert Reiling, Torsten Goldmann, Thomas Gutsmann, Walter Mier, Tobias Schürholz, Daniel Drömann, Klaus Brandenburg, Guillermo Martinez de Tejada

    Published 2015-01-01
    Get full text
    Article
  8. 8
    Phosphatidylserine exposure is required for ADAM17 sheddase function

    Phosphatidylserine exposure is required for ADAM17 sheddase function by Anselm Sommer, Felix Kordowski, Joscha Büch, Thorsten Maretzky, Astrid Evers, Jörg Andrä, Stefan Düsterhöft, Matthias Michalek, Inken Lorenzen, Prasath Somasundaram, Andreas Tholey, Frank D. Sönnichsen, Karl Kunzelmann, Lena Heinbockel, Christian Nehls, Thomas Gutsmann, Joachim Grötzinger, Sucharit Bhakdi, Karina Reiss

    Published 2016-05-01
    Get full text
    Article

Search Tools: